Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia)

J Hum Virol. 2001 Jan-Feb;4(1):35-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Resistance, Microbial / genetics
  • Drug Resistance, Multiple / genetics
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • HIV Infections / virology*
  • HIV Protease / genetics*
  • HIV Protease Inhibitors / pharmacology
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / enzymology*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification
  • Humans
  • Male
  • Prevalence
  • Recombination, Genetic
  • Reverse Transcriptase Inhibitors / pharmacology
  • Spain / epidemiology

Substances

  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • HIV Reverse Transcriptase
  • HIV Protease